|
1
|
Marques-Magalhães Â, Graça I,
Miranda-Gonçalves V, Henrique R, Lopez M, Arimondo PB and Jerónimo
C: Anti-neoplastic and demethylating activity of a newly
synthetized flavanone-derived compound in renal cell carcinoma cell
lines. Biomed Pharmacother. 141:1116812021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Medina-Rico M, Ramos HL, Lobo M, Romo J
and Prada JG: Epidemiology of renal cancer in developing countries:
Review of the literature. Can Urol Assoc J. 12:E154–E162. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hsieh JJ, Purdue MP, Signoretti S, Swanton
C, Albiges L, Schmidinger M, Heng DY, Larkin J and Ficarra V: Renal
cell carcinoma. Nat Rev Dis Primers. 3:170092017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sathianathen NJ, Krishna S, Anderson JK,
Weight CJ, Gupta S, Konety BR and Griffith TS: The current status
of immunobased therapies for metastatic renal-cell carcinoma.
Immunotargets Ther. 6:83–93. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Argiris A, Harrington KJ, Tahara M,
Schulten J, Chomette P, Ferreira Castro A and Licitra L:
Evidence-based treatment options in recurrent and/or metastatic
squamous cell carcinoma of the head and neck. Front Oncol.
7:722017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lamoral-Theys D, Andolfi A, Van
Goietsenoven G, Cimmino A, Le Calvé B, Wauthoz N, Mégalizzi V, Gras
T, Bruyère C, Dubois J, et al: Lycorine, the main phenanthridine
Amaryllidaceae alkaloid, exhibits significant antitumor activity in
cancer cells that display resistance to proapoptotic stimuli: An
investigation of structure-activity relationship and mechanistic
insight. J Med Chem. 52:6244–6256. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hwang YC, Chu JJ, Yang PL, Chen W and
Yates MV: Rapid identification of inhibitors that interfere with
poliovirus replication using a cell-based assay. Antiviral Res.
77:232–236. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bendaif H, Melhaoui A, Ramdani M,
Elmsellem H, Douez C and El Ouadi Y: Antibacterial activity and
virtual screening by molecular docking of lycorine from Pancratium
foetidum Pom (Moroccan endemic Amaryllidaceae). Microb Pathog.
115:138–145. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fürst R: Narciclasine-an Amaryllidaceae
alkaloid with potent antitumor and anti-inflammatory properties.
Planta Med. 82:1389–1394. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cole ER, de Andrade JP, Filho JFA, Schmitt
EFP, Alves-Araújo A, Bastida J, Endringer DC, de S Borges W and
Lacerda V: Cytotoxic and genotoxic activities of alkaloids from the
bulbs of griffinia gardneriana and habranthus itaobinus
(Amaryllidaceae). Anticancer Agents Med Chem. 19:707–717. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gao L, Feng Y, Ge C, Xu X, Wang S, Li X,
Zhang K, Wang C, Dai F and Xie S: Identification of molecular
anti-metastasis mechanisms of lycorine in colorectal cancer by
RNA-seq analysis. Phytomedicine. 85:1535302021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu J, Hu WX, He LF, Ye M and Li Y:
Effects of lycorine on HL-60 cells via arresting cell cycle and
inducing apoptosis. FEBS Lett. 578:245–250. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li L, Dai HJ, Ye M, Wang SL, Xiao XJ,
Zheng J, Chen HY, Luo YH and Liu J: Lycorine induces cell-cycle
arrest in the G0/G1 phase in K562 cells via HDAC inhibition. Cancer
Cell Int. 12:492012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Roy M, Liang L, Xiao X, Peng Y, Luo Y,
Zhou W, Zhang J, Qiu L, Zhang S, Liu F, et al: Lycorine
downregulates HMGB1 to inhibit autophagy and enhances bortezomib
activity in multiple myeloma. Theranostics. 6:2209–2224. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hu M, Peng S, He Y, Qin M, Cong X, Xing Y,
Liu M and Yi Z: Lycorine is a novel inhibitor of the growth and
metastasis of hormone-refractory prostate cancer. Oncotarget.
6:15348–15361. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hu M, Yu Z, Mei P, Li J, Luo D, Zhang H,
Zhou M, Liang F and Chen R: Lycorine induces autophagy-associated
apoptosis by targeting MEK2 and enhances vemurafenib activity in
colorectal cancer. Aging (Albany NY). 12:138–155. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cheng J, Fan YQ, Liu BH, Zhou H, Wang JM
and Chen QX: ACSL4 suppresses glioma cells proliferation via
activating ferroptosis. Oncol Rep. 43:147–158. 2020.PubMed/NCBI
|
|
19
|
Ooko E, Saeed ME, Kadioglu O, Sarvi S,
Colak M, Elmasaoudi K, Janah R, Greten HJ and Efferth T:
Artemisinin derivatives induce iron-dependent cell death
(ferroptosis) in tumor cells. Phytomedicine. 22:1045–1054. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Houessinon A, François C, Sauzay C,
Louandre C, Mongelard G, Godin C, Bodeau S, Takahashi S, Saidak Z,
Gutierrez L, et al: Metallothionein-1 as a biomarker of altered
redox metabolism in hepatocellular carcinoma cells exposed to
sorafenib. Mol Cancer. 15:382016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Qin Y, Qiao Y, Wang D, Tang C and Yan G:
Ferritinophagy and ferroptosis in cardiovascular disease:
Mechanisms and potential applications. Biomed Pharmacother.
141:111872Jul 7–2021.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu X, Yang Y, Xiang L and Zhang C: The
fate of melanocyte: Mechanisms of cell death in vitiligo. Pigment
Cell Melanoma Res. 34:256–267. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu H, Guo P, Xie X, Wang Y and Chen G:
Ferroptosis, a new form of cell death, and its relationships with
tumourous diseases. J Cell Mol Med. 21:648–657. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yuan H, Li X, Zhang X, Kang R and Tang D:
Identification of ACSL4 as a biomarker and contributor of
ferroptosis. Biochem Biophys Res Commun. 478:1338–1343. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jimenez A, Santos A, Alonso G and Vazquez
D: Inhibitors of protein synthesis in eukarytic cells. Comparative
effects of some amaryllidaceae alkaloids. Biochim Biophys Acta.
425:342–348. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang H, Gong Y, Liang L, Xiao L, Yi H, Ye
M, Roy M, Xia J, Zhou W, Yang C, et al: Lycorine targets multiple
myeloma stem cell-like cells by inhibition of Wnt/beta-catenin
pathway. Br J Haematol. 189:1151–1164. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu J, Kang R and Tang D: Signaling
pathways and defense mechanisms of ferroptosis. FEBS J. Jun
6–2021.(Epub ahead of print). doi: 10.1111/febs.16059. View Article : Google Scholar
|
|
28
|
Ni J, Chen K, Zhang J and Zhang X:
Inhibition of GPX4 or mTOR overcomes resistance to lapatinib via
promoting ferroptosis in NSCLC cells. Biochem Biophys Res Commun.
567:154–160. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang J, Ma S, Xu R, Wei Y, Zhang J, Zuo T,
Wang Z, Deng H, Yang N and Shen Q: Smart biomimetic metal organic
frameworks based on ROS-ferroptosis-glycolysis regulation for
enhanced tumor chemo-immunotherapy. J Control Release. 334:21–33.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wenzel SE, Tyurina YY, Zhao J, St Croix
CM, Dar HH, Mao G, Tyurin VA, Anthonymuthu TS, Kapralov AA,
Amoscato AA, et al: PEBP1 wardens ferroptosis by enabling
lipoxygenase generation of lipid death signals. Cell.
171:628–641.e26. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chatzizacharias NA, Rosich-Medina A,
Dajani K, Harper S, Huguet E, Liau SS, Praseedom RK and Jah A:
Surgical management of hepato-pancreatic metastasis from renal cell
carcinoma. World J Gastrointest Oncol. 9:70–77. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ko JJ, Xie W, Kroeger N, Lee JL, Rini BI,
Knox JJ, Bjarnason GA, Srinivas S, Pal SK, Yuasa T, et al: The
international metastatic renal cell carcinoma database consortium
model as a prognostic tool in patients with metastatic renal cell
carcinoma previously treated with first-line targeted therapy: A
population-based study. Lancet Oncol. 16:293–300. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Roy M, Liang L, Xiao X, Feng P, Ye M and
Liu J: Lycorine: A prospective natural lead for anticancer drug
discovery. Biomed Pharmacother. 107:615–624. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen D, Cai J, Yin J, Jiang J, Jing C, Zhu
Y, Cheng J, Di Y, Zhang Y, Cao M, et al: Lycorine-derived
phenanthridine downregulators of host Hsc70 as potential hepatitis
C virus inhibitors. Future Med Chem. 7:561–570. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li SY, Chen C, Zhang HQ, Guo HY, Wang H,
Wang L, Zhang X, Hua SN, Yu J, Xiao PG, et al: Identification of
natural compounds with antiviral activities against SARS-associated
coronavirus. Antiviral Res. 67:18–23. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Guo J, Xu B, Han Q, Zhou H, Xia Y, Gong C,
Dai X, Li Z and Wu G: Ferroptosis: A novel anti-tumor action for
cisplatin. Cancer Res Treat. 50:445–460. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Belavgeni A, Bornstein SR and Linkermann
A: Prominin-2 suppresses ferroptosis sensitivity. Dev Cell.
51:548–549. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu N, Lin X and Huang C: Activation of
the reverse transsulfuration pathway through NRF2/CBS confers
erastin-induced ferroptosis resistance. Br J Cancer. 122:279–292.
2020. View Article : Google Scholar : PubMed/NCBI
|
